HepSAY
hepatitis news and views from SA
Clean needle program tops the list of strategies outlined in a consensus statement released by the Harm Reduction in Prisons Working Group. The statement aims to provide a clear, concise overview of evidence-based harm reduction interventions needed to reduce injecting-related harms in Australian prisons.
Continue reading “10 Ways to Reduce Blood-Borne Viruses in Prisons”
Australian policy makers must act to reduce the spread of blood-borne viruses (BBVs) in prisons or we won’t be able to achieve critical public health goals like eliminating hepatitis C. This was the call in a consensus statement released by the Harm Reduction in Prisons Working Group.
Moorundi Aboriginal Controlled Health Service will soon be offering hepatitis C point of care testing (POCT) to the community, along with its new Clean Needle Program (CNP) at the service’s Murray Bridge site. The initiative is part of a push to bring hepatitis rapid testing to regional South Australia, under the umbrella of the world-first National Australia HCV Point of Care Testing Program (HCVPOCT).
Author Cecilia LimPosted on Leave a comment on Connections Improve Hepatitis C Care for People who are Homeless Aaron* was shocked when his hepatitis C rapid test came back positive. When he was approached by a nurse and peer worker at the Hutt Street Centre to get tested, he had been pretty sure his results would be ok.
If you’re homeless and have no symptoms, testing for hep C is probably low on the list of priorities. Aaron considered himself pretty clued in about blood-borne virus risk; he’d been injecting drugs for many years and was an expert in technique, always using clean equipment.
Continue reading “Connections Improve Hepatitis C Care for People who are Homeless”
A hunt will soon be on to find 50,000 Australians with hepatitis C who are missing out on getting cured.
Finding 50,000 campaign will target geographically dispersed and socially diverse people who so far, have not been reached by the “business-as-usual” national hepatitis C response.
Despite having been one of the countries leading in the global campaign to eliminate viral hepatitis, Australia may now not meet its 2022 national hepatitis C treatment target or the 2030 global target.
Continue reading “Hepatitis C – Australia likely to miss targets”
